BIRC5 and neoplasm: As a member of IAPs, Survivin has received more and more attention because of its anti-apoptotic effects and tumor chemotherapy resistance (Wang et al., 2013; Rivadeneira et al., 2015; Garg et al., 2016; Khan et al., 2017).